The Securities and Exchange Commission today announced charges against Parallax Health Sciences Inc. for making misleading statements about its efforts to fight COVID-19. The SEC also charged Parallax’s Chief Executive Officer Paul Arena and its…
Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.
